Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)
Sarah I. Jawed, Patricia L. Myskowski, Sarah McCue Horwitz, et al.
Journal of the American Academy of Dermatology (2014) Vol. 70, Iss. 2, pp. 223.e1-223.e17
Closed Access | Times Cited: 326

Showing 1-25 of 326 citing articles:

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice–Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue
Joseph E. Schwartz, Anand Padmanabhan, Nicole A. Aqui, et al.
Journal of Clinical Apheresis (2016) Vol. 31, Iss. 3, pp. 149-338
Closed Access | Times Cited: 668
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
Joseph E. Schwartz, Jeffrey L. Winters, Anand Padmanabhan, et al.
Journal of Clinical Apheresis (2013) Vol. 28, Iss. 3, pp. 145-284
Closed Access | Times Cited: 581
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017
Franz Trautinger, Johanna Eder, Chalid Assaf, et al.
European Journal of Cancer (2017) Vol. 77, pp. 57-74
Open Access | Times Cited: 419
Retinoic acid receptors: From molecular mechanisms to cancer therapy
Alessandra di Masi, Loris Leboffe, Elisabetta De Marinis, et al.
Molecular Aspects of Medicine (2014) Vol. 41, pp. 1-115
Closed Access | Times Cited: 342
Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019
Rafael F. Duarte, Myriam Labopin, Peter Bader, et al.
Bone Marrow Transplantation (2019) Vol. 54, Iss. 10, pp. 1525-1552
Open Access | Times Cited: 288
Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022
John A. Snowden, Isabel Sánchez‐Ortega, Selim Corbacioglu, et al.
Bone Marrow Transplantation (2022) Vol. 57, Iss. 8, pp. 1217-1239
Open Access | Times Cited: 258
Lack of durable disease control with chemotherapy for mycosis fungoides and Sézary syndrome: a comparative study of systemic therapy
Charlotte FM Hughes, Amit Khot, Christopher McCormack, et al.
Blood (2014) Vol. 125, Iss. 1, pp. 71-81
Open Access | Times Cited: 202
Modern Radiation Therapy for Primary Cutaneous Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group
Lena Specht, Bouthaina S. Dabaja, Tim Illidge, et al.
International Journal of Radiation Oncology*Biology*Physics (2015) Vol. 92, Iss. 1, pp. 32-39
Open Access | Times Cited: 191
The Human Microbiota and Skin Cancer
Yu Ri Woo, Sang Hyun Cho, Jeong Deuk Lee, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1813-1813
Open Access | Times Cited: 81
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023
Johanna Latzka, Chalid Assaf, M. Bagot, et al.
European Journal of Cancer (2023) Vol. 195, pp. 113343-113343
Open Access | Times Cited: 68
Chromatin Accessibility Landscape of Cutaneous T Cell Lymphoma and Dynamic Response to HDAC Inhibitors
Kun Qu, Lisa C. Zaba, Ansuman T. Satpathy, et al.
Cancer Cell (2017) Vol. 32, Iss. 1, pp. 27-41.e4
Open Access | Times Cited: 158
Extracorporeal Photopheresis—An Overview
A. Cho, Christian Jantschitsch, Robert Knobler
Frontiers in Medicine (2018) Vol. 5
Open Access | Times Cited: 102
Tissue-resident memory T cells and their biological characteristics in the recurrence of inflammatory skin disorders
Ling Chen, Zhu Shen
Cellular and Molecular Immunology (2019) Vol. 17, Iss. 1, pp. 64-75
Open Access | Times Cited: 89
Activation of retinoid X receptor by bexarotene attenuates neuroinflammation via PPARγ/SIRT6/FoxO3a pathway after subarachnoid hemorrhage in rats
Yuchun Zuo, Lei Huang, Budbazar Enkhjargal, et al.
Journal of Neuroinflammation (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 79
The Role of TRPA1 in Skin Physiology and Pathology
Roberto Maglie, Daniel Souza Monteiro de Araújo, Emiliano Antiga, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 3065-3065
Open Access | Times Cited: 57
Single-cell transcriptomics links malignant T cells to the tumor immune landscape in cutaneous T cell lymphoma
Xiangjun Liu, Shanzhao Jin, Simeng Hu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 57
Gene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators
Ivan V. Litvinov, Michael T. Tetzlaff, P Thibault, et al.
OncoImmunology (2017) Vol. 6, Iss. 5, pp. e1306618-e1306618
Open Access | Times Cited: 87
Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB
Jan P. Nicolay, Karin Müller‐Decker, Anne Schroeder, et al.
Blood (2016) Vol. 128, Iss. 6, pp. 805-815
Open Access | Times Cited: 78
The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL)
Ivan V. Litvinov, Elena Netchiporouk, Brendan Cordeiro, et al.
Clinical Cancer Research (2015) Vol. 21, Iss. 12, pp. 2820-2829
Open Access | Times Cited: 77
Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines
Ivan V. Litvinov, Brendan Cordeiro, Simon Fredholm, et al.
Cell Cycle (2014) Vol. 13, Iss. 18, pp. 2975-2982
Open Access | Times Cited: 70
IPH4102, a Humanized KIR3DL2 Antibody with Potent Activity against Cutaneous T-cell Lymphoma
Anne Marie‐Cardine, Nicolas Viaud, Nicolas Thonnart, et al.
Cancer Research (2014) Vol. 74, Iss. 21, pp. 6060-6070
Closed Access | Times Cited: 69
Comparison of Narrowband UV-B With Psoralen–UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides
Kevin Phan, Vignesh Ramachandran, Hiva Fassihi, et al.
JAMA Dermatology (2019) Vol. 155, Iss. 3, pp. 335-335
Open Access | Times Cited: 63
Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis
Joseph R. Stoll, Jonathan Willner, Yuna Oh, et al.
Journal of the American Academy of Dermatology (2021) Vol. 85, Iss. 5, pp. 1073-1090
Closed Access | Times Cited: 41
Bexarotene-Activated Retinoid X Receptors Regulate Neuronal Differentiation and Dendritic Complexity
Aurélien Mounier, Данко Георгиев, Kyong Nyon Nam, et al.
Journal of Neuroscience (2015) Vol. 35, Iss. 34, pp. 11862-11876
Open Access | Times Cited: 58
Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary Syndrome
Louise Photiou, Carrie Van Der Weyden, Christopher McCormack, et al.
Current Oncology Reports (2018) Vol. 20, Iss. 4
Closed Access | Times Cited: 58
Page 1 - Next Page

Scroll to top